MYBL2 and lung adenocarcinoma: By integrating the ChIP-seq data with RNA-seq data generated upon the knockdown of MYBL2 and FOXM1, we revealed that MYBL2 and FOXM1 act as transcriptional activators in lung adenocarcinoma.